This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (University of Oxford/John Cairns via AP)

This undated photo issued by the University of Oxford shows of vial of coronavirus vaccine developed by AstraZeneca and Oxford University, in Oxford, England. (University of Oxford/John Cairns via AP)

Canada can make vaccines, just not the ones leading the COVID-19 race

Canada has spent more than $1 billion to pre-order seven different developing COVID-19 vaccines

The head of a Canadian biotech industry association says Canada can and does make vaccines — just not the ones expected first to help stop the COVID-19 pandemic.

Prime Minister Justin Trudeau created a firestorm Tuesday when he said Canadians will have to wait a bit to get vaccinated for COVID-19 because the first doses off the production lines will be used in the countries where they are made.

So while vaccinations might start next month in the United States, the United Kingdom and Germany, it will be January at the earliest before any doses are injected in this country.

Canada, said Trudeau, “no longer has any domestic production capacity for vaccines” and it makes sense that the countries that do will prioritize their own citizens.

Andrew Casey, the CEO of BioteCanada, told The Canadian Press Wednesday that Canada does produce vaccines but the technology for the leading COVID-19 vaccine candidates is so new, the manufacturing capacity is being built alongside the vaccines themselves.

“This is the first time the technology has actually been applied,” he said. “So you have to then build the facility to manufacture at scale, which is a challenge.”

While pharmaceutical company Sanofi has a vaccine plant in Toronto and GlaxoSmithKline has one in Quebec, both make protein-based vaccines, such as the more familiar ones Canadians get every year for the flu.

Canada has spent more than $1 billion to pre-order seven different developing COVID-19 vaccines, and only one being developed jointly by Sanofi and GlaxoSmithKline uses the protein technology.

The first two vaccines expected on the market, from Pfizer and Moderna, each use genetic material known as messenger ribonucleic acid or mRNA. A third with promising trial results, from AstraZeneca, uses a modified common-cold virus that normally infects chimpanzees. Each type trains the human body to develop antibodies to SARS-CoV-2, the virus that causes COVID-19.

Casey said a protein-vaccine maker can’t just start making the bioengineered vaccines.

“One is like making wine, one’s like making Coke,” he said. “Yes, they both grow in bottles. Yes, you can drink both out of a glass. But the manufacturing processes used for the two is so completely different. You can’t just say well, we’ll shut down the protein one, and we’ll switch over to the mRNA.”

READ MORE: Canada’s inability to manufacture vaccines in-house will delay distribution: Trudeau

Conservative health critic Michelle Rempel Garner demanded in question period Wednesday that the government explain whether Canada had even tried to convince the companies to make their products here.

Trudeau didn’t answer, but if those negotiations happened, they have not been successful.

Pfizer is expanding production facilities in Kalamazoo, Mich. and Puurs, Belgium to produce most of its vaccine. The company has said it is open to others manufacturing it, but that the technology is difficult to transfer.

Moderna has a 10-year exclusive agreement with Swiss-based Lonza Group AC to make its vaccine, mainly in facilities in New Hampshire and Switzerland. Lonza chairman Albert Baehny said earlier this month the new technology meant Lonza had to remake its production lines “from scratch.”

AstraZeneca, which has promised three billion doses of its vaccine, has signed contract deals with at least two dozen manufacturers around the world to produce its vaccine but not in Canada.

A spokesman for Innovation Minister Navdeep Bains said the biomanufacturing sector has been declining in Canada since the mid-1980s.

“When this pandemic began Canada had no flexible, large-scale, bio-manufacturing capacity suitable for a COVID-19 vaccine,” said John Power.

He said Canada has been working with experts to address the issue and has made investments, including $140 million in a new National Research Council plant in Montreal.

The NRC said Wednesday the Biologics Manufacturing Centre will be finished next July. It doesn’t have an agreement yet to produce a specific vaccine, but is being built so it can produce several biologic vaccines, including of the type being made by AstraZeneca. It will not be able to make mRNA vaccines like those from Moderna or Pfizer.

It is supposed to be able to produce two million doses a month before the end of 2021.

A spokeswoman for GlaxoSmithKline told The Canadian Press the company’s Ste-Foy, Que., plant will be part of production of the GSK vaccine eventually but timelines and specifics aren’t yet available.

A Canadian-made vaccine from Quebec-based Medicago is also expected to be in production in Canada next year.

Medicago CEO Bruce Clark said the company has been able to adapt a vaccine for influenza to target COVID-19 instead, noting such an adaptation is one of the advantages of biologic vaccines. But Clark said one of the disadvantages is that it’s harder to transfer the technology of biologics to be made in other places.

Medicago has facilities in Quebec and North Carolina and is building a new one in Quebec. The existing ones can make about 50 million doses by the end of next year, while the new plant will be able to do as many as a billion annually.

The company has been talking to the federal government for years to get funding for a “full-scale manufacturing facility,” he said.

“We were not successful,” said Clark. “It’s really only been in the context of the pandemic that we’ve seen funds be freed up to commit to capacity in Canada.”

Last month Ottawa agreed to provide $173 million to Medicago for research on its vaccine and construction of an expanded facility. Clark said the 2023 completion date for the new plant could be bumped up with more money.

None of the vaccines in question have finished clinical trials and all must also be approved by Health Canada before they can be used here.

Mia Rabson, The Canadian Press


Like us on Facebook and follow us on Twitter.

Want to support local journalism during the pandemic? Make a donation here.

Coronavirusvaccines

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

The City of Surrey is seeking public input on its walking routes, including Semiahmoo Trail. (Tracy Holmes photo)
Surrey seeks input from seniors on city’s walking routes

Online survey is part of city’s Age Friendly Strategy

Chief Constable Norm Lipinski, Surrey Police Service. (Submitted photo)
Surrey chief constable says ‘comprehensive’ public engagement to be done this year

Norm Lipinski says Surrey Police Service has ‘good momentum’

Dyllan Petrin is charged related to an ongoing investigation in Surrey involving a kidnapping and assault that occurred in July, 2019. (Photo: Surrey RCMP)
Man arrested in connection to kidnapping, murder investigations: Surrey RCMP

Police say Dyllan Petrin was arrested in Vancouver

Crews work to clear the aftermath of a three-vehicle collision that occurred Wednesday morning (Jan. 20, 2021) at the intersection of 16 Avenue and 156 Street. (Tracy Holmes photo)
One person to hospital following three-vehicle collision in South Surrey

Police say it appears one driver went through intersection ‘as if it was not even there’

Maj.-Gen. Dany Fortin, vice-president of logistics and operations at the Public Health Agency of Canada, speaks at a news conference on the COVID-19 pandemic in Ottawa, on Friday, Jan. 15, 2021. THE CANADIAN PRESS/Justin Tang
B.C. records 500 new COVID-19 cases Wednesday, 14 deaths

Outbreak at Surrey Pretrial jail, two more in health care

(Pxhere)
B.C. nurse suspended after using Tensor bandage to trap long-term care patient in room

Susan Malloch voluntarily agreed to a three-day suspension of her certificate of registration

Abbotsford’s Skully White (left), who donated his kidney in December, has started a campaign to find other recipients and donors. The first candidate is retired police officer Gavin Quon. White owns and operates a hotdog stand, Lullys Food Experience, out of the Abbotsford Canadian Tire parking lot. (Facebook photo)
After donating his kidney, Abbotsford hotdog king starts donor campaign

Skully White donated his kidney to customer Tim Hiscock in December

Toronto-based director Michelle Latimer was recently scrutinized after years of claiming she was of Algonquin and Metis descent. (CANADIAN PRESS/Chris Young)
Haida activist calls for hefty fines, jail time against those who claim to be Indigenous

Filmmaker Tamara Bell proposing the Indigenous Identity Act – to dissuade ‘Indigenous identity theft’

Cannabis bought in British Columbia (Ashley Wadhwani/Black Press Media)
Is it time to start thinking about greener ways to package cannabis?

Packaging suppliers are still figuring eco-friendly and affordable packaging options that fit the mandates of Cannabis Regulations

(File)
Man allegedly bites Vancouver cop during arrest for outstanding warrant

The officer was treated in hospital for the bite wounds

(File Photo)
Interior Health says COVID positivity rates in Fernie area actually 10-12%

IH say the rates are not as high as previously claimed by the region’s top doctor

Black bear cubs Athena and Jordan look on from their enclosure at the North Island Wildlife Recovery Association in Errington, B.C., on July 8, 2015. Conservation Officer Bryce Casavant won the hearts of animal lovers when he opted not to shoot the baby bears in July after their mother was destroyed for repeatedly raiding homes near Port Hardy, B.C. THE CANADIAN PRESS/Chad Hipolito
Supreme Court quashes review of B.C. conservation officer who refused to euthanize bears

Bryce Casavant was dismissed from his job for choosing not to shoot the cubs in 2015

Francina Mettes and Thomas Schouten with the 200-page document they submitted in December of 2018. (Travis Paterson/News Staff)
Dutch man, 94, facing unwanted trip home can stay in B.C. with wife of 45 years

Immigration offices cuts red tape so couple of 45 years can stay together in Victoria area

Most Read